Ponvory (Ponesimod) for Multiple Sclerosis

Overview
Ponvory is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of multiple sclerosis. Ponvory is also known by its drug name, ponesimod.

Ponvory is a member of a class of drugs called sphingosine-1-phosphate receptor modulators. Ponvory is believed to work by blocking abnormal white blood cells from leaving the lymph nodes, which protects the body’s nerves from being attacked by them.

How do I take it?
Ponvory is given orally as a tablet. It should be taken exactly as prescribed by the physician.

Side effects
The FDA-approved label for Ponvory lists common side effects that include upper respiratory tract infection, hepatic transaminase elevation (an increase in an enzyme that can indicate liver damage), and high blood pressure.

Serious side effects listed for Ponvory include infections, slow and irregular heartbeat, decreased lung function, liver injury, skin malignancies, and fetal harm.

For more details about this treatment, visit:
Ponvory (ponesimod) — Janssen